Clinical trial
Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk…
NCT00195000 · Weill Medical College of Cornell University, Other · Completed
Key facts
| NCT number | NCT00195000 |
|---|---|
| Title | Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS |
| Official title | Phase II Evaluation of Gemtuzumab Ozogamicin in Combination With Cytarabine in Untreated Patients Above the Age of 60 Years With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia, Myelodysplastic Syndrome |
| Intervention type | Drug |
| Interventions | Mylotarg, Cytarabine |
| Enrollment | 43 |
| Start date | May 1, 2003 |
| Primary completion | May 1, 2006 |
| Completion | Feb 1, 2008 |
| First posted | Sep 19, 2005 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: